Doctor Anywhere, a tech-led healthcare company headquartered in Singapore, has on Thursday announced a $40.8 million Series C1 extension round with participating investors including Square Peg and Novo Holdings. The influx of funds will be directed to strategically drive next-generation healthcare innovation within the company, and to deepen its presence in secondary care.